CLB FY 2013 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2013 Earnings

Reported February 13, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$1.1B	—	$981M	—	9.4%
Op. Income	$333M	—	$297M	—	12.2%
Gross Margin	35.9%	—	34.3%	—	1.6pp
Net Margin	22.6%	—	22.0%	—	0.6pp
EPS (Diluted)	$5.28	—	$4.54	—	16.3%
Free Cash Flow	$259M	—	$204M	—	26.8%

Revenue Flow

Item	Amount
REVENUE	$1.1B
Cost of Revenue	$688M
GROSS PROFIT	$385M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$52M
SG&A Expenses	$52M
Other Expenses	$338.0K
Operating Expenses	$52M
Cost & Expenses	$740M
OPERATING INCOME	$333M
Interest Income	$776.0K
Interest Expense	$9M
Other Income/Expenses	-$9M
INCOME BEFORE TAX	$324M
Income Tax Expense	$81M
Net Income from Continuing Ops	$243M
Net Income from Discontinued Ops	$0
Other Adjustments	$177.0K
NET INCOME	$243M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$243M
D&A	$25M
EBIT	$333M
EBITDA	$359M
EPS	$5
EPS Diluted	$5

Income Statement

Item	Amount
REVENUE	$1.1B
Cost of Revenue	$688M
GROSS PROFIT	$385M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$52M
SG&A Expenses	$52M
Other Expenses	$338.0K
Operating Expenses	$52M
Cost & Expenses	$740M
OPERATING INCOME	$333M
Interest Income	$776.0K
Interest Expense	$9M
Other Income/Expenses	-$9M
INCOME BEFORE TAX	$324M
Income Tax Expense	$81M
Net Income from Continuing Ops	$243M
Net Income from Discontinued Ops	$0
Other Adjustments	$177.0K
NET INCOME	$243M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$243M
D&A	$25M
EBIT	$333M
EBITDA	$359M
EPS	$5
EPS Diluted	$5

Cash Flow Statement

Item	Amount
Net Income	$243M
Depreciation & Amortization	$25M
Stock-Based Compensation	$21M
Deferred Income Tax	$7M
Other Non-Cash Items	-$4M
Change in Working Capital	$7M
OPERATING CASH FLOW	$298M
Capital Expenditure	-$39M
Acquisitions (Net)	-$98.0K
Purchases of Investments	-$7M
Sales/Maturities of Investments	$1M
Other Investing Activities	-$38M
NET CASH FROM INVESTING	-$43M
Net Debt Issuance	$33M
Common Stock Repurchased	-$227M
Common Dividends Paid	-$59M
Other Financing Activities	$4M
NET CASH FROM FINANCING	-$249M
FREE CASH FLOW	$259M
Net Change in Cash	$6M

Balance Sheet

Item	Amount
Cash & Equivalents	$25M
Short-Term Investments	$0
Net Receivables	$201M
Inventory	$47M
Other Current Assets	$18M
TOTAL CURRENT ASSETS	$304M
PP&E (Net)	$139M
Goodwill	$163M
Intangible Assets	$11M
Long-Term Investments	$2M
Tax Assets	$4M
Other Non-Current Assets	-$6M
TOTAL NON-CURRENT ASSETS	$357M
TOTAL ASSETS	$661M
Account Payables	$51M
Short-Term Debt	$0
Deferred Revenue	$11M
Other Current Liabilities	$35M
TOTAL CURRENT LIABILITIES	$136M
Long-Term Debt	$267M
Deferred Revenue NC	-$9M
Deferred Tax Liabilities	$9M
Other Non-Current Liabilities	$80M
TOTAL NON-CURRENT LIABILITIES	$356M
TOTAL LIABILITIES	$492M
Common Stock	$1M
Additional Paid-In Capital	$0
Retained Earnings	$416M
Treasury Stock	-$245M
Accum. Other Comp. Income	-$9M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$169M
Minority Interest	$6M
TOTAL EQUITY	$175M
TOTAL LIABILITIES & EQUITY	$661M
Total Debt	$267M
Net Debt	$242M